Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rickenbach

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
HIV Medicine|August 15, 2006
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyT R Glass, C Ungsedhapand, M Wolbers, et al.
British Journal of Cancer|November 16, 2006
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort StudyS Franceschi, J Polesel, M Rickenbach, et al.
Gut|July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infectionB Helbling, K Overbeck, J-J Gonvers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyK Boubaker, M Flepp, P Sudre, et al.
AIDS (London, England)|November 8, 2001
Acute HIV infection: impact on the spread of HIV and transmission of drug resistanceS Yerly, S Vora, P Rizzardi, et al.
HIV Medicine|October 20, 2010
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort StudyJ Young, A U Scherrer, H F Günthard, et al.
HIV Medicine|August 14, 2015
Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational periodK Aebi-Popp, R Kouyos, B Bertisch, et al.
HIV Medicine|May 21, 2014
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equationsK Petoumenos, P Reiss, L Ryom, et al.
The Journal of Infectious Diseases|March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?E Fontas, F van Leth, C A Sabin, et al.
British Journal of Cancer|July 1, 2010
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort StudyS Franceschi, M Lise, G M Clifford, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
HIV Medicine|August 15, 2006
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyT R Glass, C Ungsedhapand, M Wolbers, et al.
British Journal of Cancer|November 16, 2006
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort StudyS Franceschi, J Polesel, M Rickenbach, et al.
Gut|July 16, 2008
Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infectionB Helbling, K Overbeck, J-J Gonvers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2001
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort StudyK Boubaker, M Flepp, P Sudre, et al.
AIDS (London, England)|November 8, 2001
Acute HIV infection: impact on the spread of HIV and transmission of drug resistanceS Yerly, S Vora, P Rizzardi, et al.
HIV Medicine|October 20, 2010
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort StudyJ Young, A U Scherrer, H F Günthard, et al.
HIV Medicine|August 14, 2015
Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational periodK Aebi-Popp, R Kouyos, B Bertisch, et al.
HIV Medicine|May 21, 2014
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equationsK Petoumenos, P Reiss, L Ryom, et al.
The Journal of Infectious Diseases|March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?E Fontas, F van Leth, C A Sabin, et al.
British Journal of Cancer|July 1, 2010
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort StudyS Franceschi, M Lise, G M Clifford, et al.
Pageof 9